Purchases and Sales Made in Q2 2024 in Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX) during Q2 2024. The information is specifically focused on institutions that hold shares of Lineage Cell Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2024
Q2 2024
|
Mariner, LLC
Overland Park, KS |
SELL
|
- |
-2K- 11.88% |
$1.78K - $2.94K
|
14.8K
$10.1K
|
|
Aug 14, 2024
Q2 2024
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-2.64K- 19.76% |
$2.35K - $3.87K
|
10.7K
$7.28K
|
|
Jul 25, 2024
Q2 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-3.44K- 54.68% |
$3.07K - $5.06K
|
2.86K
$1.94K
|
|
Aug 13, 2024
Q2 2024
|
Quadrant Private Wealth Management, LLC
Bethlehem, PA |
SELL
|
- |
-5K- 33.33% |
$4.45K - $7.35K
|
10K
$6.8K
|
|
Aug 14, 2024
Q2 2024
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-5.66K- 93.35% |
$5.03K - $8.31K
|
403
$274
|
|
Aug 13, 2024
Q2 2024
|
Pro Share Advisors LLC
|
SELL
|
- |
-6.07K- 25.45% |
$5.4K - $8.92K
|
17.8K
$12.1K
|
|
Aug 13, 2024
Q2 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-8.3K- 12.97% |
$7.39K - $12.2K
|
55.7K
$37.9K
|
|
Aug 14, 2024
Q2 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-9.9K- 30.56% |
$8.81K - $14.6K
|
22.5K
$15.3K
|
|
Aug 07, 2024
Q2 2024
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-10K- 24.08% |
$8.9K - $14.7K
|
31.5K
$21.4K
|
|
Aug 14, 2024
Q2 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-15.6K- 1.14% |
$13.9K - $22.9K
|
1.35M
$918K
|
|
Aug 14, 2024
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-17.3K- 23.08% |
$15.4K - $25.4K
|
57.6K
$39.2K
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-40.4K- 21.67% |
$36K - $59.4K
|
146K
$99.4K
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-41.2K- 3.34% |
$36.7K - $60.6K
|
1.19M
$810K
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-42.6K- 45.3% |
$37.9K - $62.5K
|
51.4K
$34.9K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-63.6K- 45.41% |
$56.6K - $93.5K
|
76.5K
$52K
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-81.4K- 12.05% |
$72.5K - $120K
|
594K
$404K
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-82.9K- 12.24% |
$73.7K - $122K
|
594K
$404K
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-148K- 76.91% |
$131K - $217K
|
44.3K
$30.1K
|
|
Aug 14, 2024
Q2 2024
|
Prescott General Partners LLC
Boca Raton, FL |
SELL
|
- |
-1.23M- 66.52% |
$1.1M - $1.81M
|
620K
$422K
|
|
Aug 14, 2024
Q2 2024
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-1.55M- 24.8% |
$1.38M - $2.28M
|
4.7M
$3.2M
|